Tampa General Researchers Develop Innovative Device That Expands Access to Heart Transplants
Electric synchronization device earned a
"Our goal is to expand access to world-class care and save more lives," said
The Synchronization Modulation Electric Field (SMEF) device, developed by Dr.
"The SMEF device has the potential to achieve optimal preservation and transport conditions by electrically inhibiting the ischemic damage in donor hearts and maintaining cellular functions, ultimately enhancing the success rates of heart transplantation," said Lozonschi.
"Results obtained from earlier studies are expected to have high translational significance and could be readily applied to patients. However, due to the high technical demand for heart transplantation in our models, it will be impossible to perform this kind of surgery without strong support from a world-class cardiac surgeon such as Dr. Lozonschi," said Liu. "We have a great opportunity to test this novel technique in a pre-clinical model. This is a typical example of synergistic collaboration between basic researchers and clinicians."
There is a national shortage of donor organs to meet the needs of patients experiencing heart failure. Donor organs must be transplanted within just five hours, and they degrade in transit due to a lack of blood supply.
The SMEF device protects donor hearts in a way that lengthens the time available for transit from five hours to more than eight. This novel approach would directly address the shortage of available hearts for donation by extending the time donor hearts are available. The device also improves the organ's function by protecting its cellular activity during transport.
"Drs. Lozonschi and Liu make an incredible team for this translational research project that is taking foundational bench science through the rigors of pre-clinical trials. This translational research represents an excellent example of the bench-to-bedside progress that can only be accomplished at academic health systems, such as ours," said Dr.
Lockwood is also the executive vice president and chief academic officer of Tampa General Hospital.
Lozonschi and Liu were one of more than three dozen teams applying for the Interdisciplinary Research Award at the University of South Florida, with just
ABOUT TAMPA GENERAL HOSPITAL
Tampa General Hospital, a 981-bed, not-for-profit, academic health system, is one of the largest hospitals in America and delivers world-class care as the region's only center for Level l trauma and comprehensive burn care. Tampa General Hospital is the highest-ranked hospital in the market in U.S. News & World Report's 2024-2025 Best Hospitals, with two medical specialties ranking among the top 20 in the nation and eight medical specialties ranking among the top 50 best hospital programs in
ABOUT USF HEALTH
USF Health's mission is to envision and implement the future of health. It is the partnership of the USF Health Morsani College of Medicine, the College of Nursing, the College of Public Health, the Taneja College of Pharmacy, the School of Physical Therapy and Rehabilitation Sciences, the Biomedical Sciences Graduate and Postdoctoral Programs, and USF Health's multispecialty physicians' group. The University of South Florida, a high-impact research university dedicated to student success and committed to community engagement, generates an annual economic impact of more than
Media Contact:
(202) 680-9262 (cell)
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/tampa-general-researchers-develop-innovative-device-that-expands-access-to-heart-transplants-302205335.html
SOURCE Tampa General Hospital
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Whirlpool Community Golf Event Raises $3 Million for Southwest Michigan Youth
- WORKERS AT THE SPHERE JOIN TEAMSTERS
- Steep Hill Mississippi and Alchemy Analytics to Combine Under Southern Precision Analytics, Preserving Statewide Cannabis Testing Capacity
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share